AU2001240658A1 - Farnesyl protein transferase inhibitor combinations with camptothecin compounds - Google Patents
Farnesyl protein transferase inhibitor combinations with camptothecin compoundsInfo
- Publication number
- AU2001240658A1 AU2001240658A1 AU2001240658A AU4065801A AU2001240658A1 AU 2001240658 A1 AU2001240658 A1 AU 2001240658A1 AU 2001240658 A AU2001240658 A AU 2001240658A AU 4065801 A AU4065801 A AU 4065801A AU 2001240658 A1 AU2001240658 A1 AU 2001240658A1
- Authority
- AU
- Australia
- Prior art keywords
- protein transferase
- transferase inhibitor
- farnesyl protein
- camptothecin compounds
- inhibitor combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00200688 | 2000-02-29 | ||
EP00200688 | 2000-02-29 | ||
PCT/EP2001/002161 WO2001064194A2 (en) | 2000-02-29 | 2001-02-26 | Farnesyl protein transferase inhibitor combinations with camptothecin compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001240658A1 true AU2001240658A1 (en) | 2001-09-12 |
Family
ID=8171107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001240658A Abandoned AU2001240658A1 (en) | 2000-02-29 | 2001-02-26 | Farnesyl protein transferase inhibitor combinations with camptothecin compounds |
Country Status (6)
Country | Link |
---|---|
US (1) | US20030100553A1 (en) |
EP (1) | EP1261341A2 (en) |
JP (1) | JP2003525234A (en) |
AU (1) | AU2001240658A1 (en) |
CA (1) | CA2397240A1 (en) |
WO (1) | WO2001064194A2 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060106060A1 (en) * | 2004-03-18 | 2006-05-18 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies (Lansbury) |
EP1744751A4 (en) * | 2004-03-18 | 2010-03-10 | Brigham & Womens Hospital | Methods for the treatment of synucleinopathies |
US20050272722A1 (en) * | 2004-03-18 | 2005-12-08 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
US20070293539A1 (en) * | 2004-03-18 | 2007-12-20 | Lansbury Peter T | Methods for the treatment of synucleinopathies |
US20050288298A1 (en) * | 2004-03-18 | 2005-12-29 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
US20050272068A1 (en) * | 2004-03-18 | 2005-12-08 | The Brigham And Women's Hospital, Inc. | UCH-L1 expression and cancer therapy |
AU2005244768B2 (en) | 2004-04-27 | 2011-06-09 | Wellstat Biologics Corporation | Cancer treatment using viruses and camptothecins |
WO2006077424A1 (en) | 2005-01-21 | 2006-07-27 | Astex Therapeutics Limited | Pharmaceutical compounds |
US20060194821A1 (en) * | 2005-02-18 | 2006-08-31 | The Brigham And Women's Hospital, Inc. | Compounds inhibiting the aggregation of superoxide dismutase-1 |
ATE540698T1 (en) | 2005-07-14 | 2012-01-15 | Wellstat Biologics Corp | CANCER TREATMENT WITH VIRUSES, FLUOROPYRIMIDINES AND CAMPTOTHECINES |
CA2634598A1 (en) | 2005-12-23 | 2007-07-05 | Link Medicine Corporation | Treatment of synucleinopathies |
US8916552B2 (en) | 2006-10-12 | 2014-12-23 | Astex Therapeutics Limited | Pharmaceutical combinations |
WO2008044045A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
US8232402B2 (en) * | 2008-03-12 | 2012-07-31 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
US20100331363A1 (en) * | 2008-11-13 | 2010-12-30 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
CA2743717A1 (en) * | 2008-11-13 | 2010-05-20 | Link Medicine Corporation | Azaquinolinone derivatives and uses thereof |
US20110060005A1 (en) * | 2008-11-13 | 2011-03-10 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
WO2014062655A1 (en) | 2012-10-16 | 2014-04-24 | Janssen Pharmaceutica Nv | HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt |
CA2888210C (en) | 2012-10-16 | 2021-02-09 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of ror-gamma-t |
AU2013331505A1 (en) | 2012-10-16 | 2015-04-30 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of ROR-gamma-t |
US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
EP3057422B1 (en) | 2013-10-15 | 2019-05-15 | Janssen Pharmaceutica NV | Quinolinyl modulators of ror(gamma)t |
US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
JP6423423B2 (en) | 2013-10-15 | 2018-11-14 | ヤンセン ファーマシューティカ エヌ.ベー. | Rorγt alkyl-linked quinolinyl modulator |
CN108135917B (en) | 2015-09-25 | 2021-07-09 | Zy医疗 | Pharmaceutical formulations based on particles comprising polysaccharide-vitamin conjugates |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW349948B (en) * | 1995-10-31 | 1999-01-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 2-quinolone derivatives |
DE69620445T2 (en) * | 1995-12-08 | 2002-12-12 | Janssen Pharmaceutica N.V., Beerse | (IMIDAZOL-5-YL) METHYL-2-CHINOLINO DERIVATIVES AS A FARNESYL PROTEIN TRANSFERASE INHIBITOR |
TW591030B (en) * | 1997-03-10 | 2004-06-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles |
EP0977750B1 (en) * | 1997-04-25 | 2007-07-04 | Janssen Pharmaceutica N.V. | Farnesyltransferase inhibiting quinazolinones |
EP1087770A4 (en) * | 1998-06-15 | 2001-11-14 | Merck & Co Inc | Inhibitors of prenyl-protein transferase |
CA2336054A1 (en) * | 1998-07-02 | 2000-01-13 | Merck And Co., Inc. | Inhibitors of prenyl-protein transferase |
FR2787327B1 (en) * | 1998-12-21 | 2003-01-17 | Aventis Pharma Sa | COMPOSITIONS CONTAINING FARNESYL TRANSFERASE INHIBITORS |
TW531533B (en) * | 1998-12-23 | 2003-05-11 | Janssen Pharmaceutica Nv | 1,2-annelated quinoline derivatives having farnesyl transferase and geranylgeranyl transferase inhibiting activity |
-
2001
- 2001-02-26 CA CA002397240A patent/CA2397240A1/en not_active Abandoned
- 2001-02-26 WO PCT/EP2001/002161 patent/WO2001064194A2/en not_active Application Discontinuation
- 2001-02-26 JP JP2001563091A patent/JP2003525234A/en not_active Withdrawn
- 2001-02-26 AU AU2001240658A patent/AU2001240658A1/en not_active Abandoned
- 2001-02-26 US US10/220,399 patent/US20030100553A1/en not_active Abandoned
- 2001-02-26 EP EP01911702A patent/EP1261341A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1261341A2 (en) | 2002-12-04 |
JP2003525234A (en) | 2003-08-26 |
CA2397240A1 (en) | 2001-09-07 |
WO2001064194A2 (en) | 2001-09-07 |
WO2001064194A3 (en) | 2002-03-07 |
US20030100553A1 (en) | 2003-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001240658A1 (en) | Farnesyl protein transferase inhibitor combinations with camptothecin compounds | |
AU2001246477A1 (en) | Farnesyl protein transferase inhibitor combinations with platinum compounds | |
AU2001254672A1 (en) | Farnesyl protein transferase inhibitor combinations with an her2 antibody | |
AU2001258771A1 (en) | -secretase inhibitors | |
AU2001234484A1 (en) | Amide compounds for inhibiting protein kinases | |
AU2001235496A1 (en) | Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents | |
AU2001232799A1 (en) | Protein c derivatives | |
AU2001244166A1 (en) | Farnesyl protein transferase inhibitor combinations with further anti-cancer agents | |
AU2001239275A1 (en) | Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives | |
AU2001246478A1 (en) | Farnesyl protein transferase inhibitor combinations with taxane compounds | |
AU2001252147A1 (en) | Farnesyl protein transferase inhibitor combinations | |
AU2001230336A1 (en) | Fixture | |
AU2001293835A1 (en) | Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives | |
AU2001247882A1 (en) | Tricyclic protein kinase inhibitors | |
AU2001256166A1 (en) | Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives | |
HK1036279A1 (en) | Farnesyl protein transferase inhibitors. | |
AU2001253197A1 (en) | Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase | |
AU8845101A (en) | Tricyclic antitumor compounds being farnesyl protein transferase inhibitors | |
AU2001244167A1 (en) | Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives | |
AU4020897A (en) | 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors | |
AU2001242434A1 (en) | Farnesyl protein transferase inhibitor combinations with vinca alkaloids | |
AU2001272651A1 (en) | Valves | |
AU3724701A (en) | Family 5 xyloglucanases | |
AU2435199A (en) | Farnesyl transferase inhibitors | |
PL348293A1 (en) | Tricyclic farnesyl protein transferase inhibitors |